SERONEGATIVE MYASTHENIA-GRAVIS AND HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - RESPONSE TO INTRAVENOUS GAMMA-GLOBULIN AND PREDNISONE

Citation
J. Strong et Dw. Zochodne, SERONEGATIVE MYASTHENIA-GRAVIS AND HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - RESPONSE TO INTRAVENOUS GAMMA-GLOBULIN AND PREDNISONE, Canadian journal of neurological sciences, 25(3), 1998, pp. 254-256
Citations number
19
Categorie Soggetti
Clinical Neurology
ISSN journal
03171671
Volume
25
Issue
3
Year of publication
1998
Pages
254 - 256
Database
ISI
SICI code
0317-1671(1998)25:3<254:SMAHI>2.0.ZU;2-C
Abstract
Background: There are only rare reports of myasthenia gravis complicat ing human immunodeficiency virus infection. The role of immunomodulato ry therapy is unknown. Methods: Case report and literature review. Res ults: The diagnosis of human immunodeficiency virus infection followed that of myasthenia gravis in a 35-year-old man. Clinical and electrop hysiological features were diagnostic of generalized myasthenia gravis but two edrophonium chloride tests and acetylcholine receptor antibod ies were negative, Prednisone therapy and intravenous gamma globulin w ere associated with rapid clinical recovery. Conclusions: Prednisone t herapy and intravenous gamma globulin may be helpful in patients with generalized myasthenia gravis complicating HIV infection.